Drugs Controller General India, Central Drugs Standard Control Organizations called for a larger stakeholders consultation meeting on October 20th to discuss certain issues and suggestions for medical devices regulations in India. The agenda of the discussion was the inclusion of exemption of import license for imports of medical devices directly by hospitals. Dr. Vibhav Garg from Boston Scientific and Mr. Sudhakar Mairpady of BD represented AMCHAM in this meeting. Members discussed the issues and concerns related to the customer direct import process, accessories to be part of DMF of the main/parent equipment, concerns related to refurbished medical equipment, MSMEs fee related challenge to CDSCO, etc. It was recommended that industry submit a detailed list of challenges and recommendations including the change in management guidelines to CDSCO.
By joining AMCHAM India, you become part of an active and dynamic Apex Chamber of U.S. Industry in India with a membership base of more than 400 American companies in India. AMCHAM is an important voice for policy advocacy, a critical source for business intelligence, a vibrant platform for networking and expanding your business.